Abstract

Renal fibrosis is the final common pathway of various renal injuries and it leads to chronic kidney disease. Autophagy is a cellular process of degradation of damaged cytoplasmic components and regulates cell death and proliferation. Cellular response during unilateral ureteral obstruction (UUO) is tubular segment specific. Thus the role of autophagy on renal tubulointerstitial fibrosis (TIF) after UUO may be different according to segment of nephron. The role of autophagy during UUO remains unclear especially in distal tubules. In this study, we investigated the role of autophagy in distal tubules on renal TIF using conditional knockout mice in which Atg7 was genetically ablated specifically in distal tubular epithelial cell (TEC). In green fluorescent protein (GFP)-LC3 transgenic mice, GFP-LC3 puncta was highly expressed in distal tubular cells of the obstructed kidneys after UUO. Genetic deletion of Atg7 specifically in distal TEC increased renal tubulointerstial fibrosis and epithelial-mesenchymal transition-like phenotype change after UUO through Smad4-dependent transforming growth factor (TGF)-β pathway. Distal tubule-specific autophagy-deficient mice increased the accumulation of damaged mitochondria and SQSTM1/p62-positive aggregates in the obstructed kidney and resulted in increased expression of NLRP3 inflammasome, interleukin (IL) 1-β and caspase-1. Distal TEC-specific Atg7 deletion enhanced apoptosis of TECs after UUO. In summary, our data showed that autophagy in distal TEC plays a protective role in development of renal tubulointerstial fibrosis through regulating the expression of TGF-β an IL1-β after UUO.

Details

Title
Autophagy attenuates tubulointerstital fibrosis through regulating transforming growth factor-β and NLRP3 inflammasome signaling pathway
Author
Nam, Sun Ah 1 ; Wan-Young, Kim 1 ; Kim, Jin Won 1 ; Park, Sang Hee 2 ; Kim Hong Lim 3 ; Lee, Myung-Shik 4 ; Komatsu Masaaki 5   VIAFID ORCID Logo  ; Ha Hunjoo 6 ; Lim, Ji Hee 7 ; Park Cheol Whee 7 ; Yang Chul Woo 7 ; Kim, Jin 1 ; Kim, Yong Kyun 8 

 The Catholic University of Korea, Cell Death Disease Research Center, College of Medicine, Seoul, Korea (GRID:grid.411947.e) (ISNI:0000 0004 0470 4224) 
 Institute of Clinical Medicine Research of Bucheon St. Mary’s Hospital, Bucheon-si, Korea (GRID:grid.414678.8) (ISNI:0000 0004 0604 7838) 
 The Catholic University of Korea, Integrative Research Support Center, College of Medicine, Seoul, Korea (GRID:grid.411947.e) (ISNI:0000 0004 0470 4224) 
 Yonsei University College of Medicine, Severans Biomedical Research Institute and Department of Internal Medicine, Seoul, Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454) 
 Niigata University School of Medicine, Department of Biochemistry, Niigata, Japan (GRID:grid.260975.f) (ISNI:0000 0001 0671 5144) 
 Ewha Womans University, Graduate School of Pharmaceutical Sciences, College of Pharmacy, Seoul, Republic of Korea (GRID:grid.255649.9) (ISNI:0000 0001 2171 7754) 
 The Catholic University of Korea, Department of Internal Medicine, College of Medicine, Seoul, Korea (GRID:grid.411947.e) (ISNI:0000 0004 0470 4224) 
 The Catholic University of Korea, Cell Death Disease Research Center, College of Medicine, Seoul, Korea (GRID:grid.411947.e) (ISNI:0000 0004 0470 4224); The Catholic University of Korea, Department of Internal Medicine, College of Medicine, Seoul, Korea (GRID:grid.411947.e) (ISNI:0000 0004 0470 4224) 
Publication year
2019
Publication date
Jan 2019
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2172175759
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.